2005
Significance of qualitative PCR detection metod for preemtive therapy of cytomegalovirus infection in patiens after allogeneic hematopoietic stem cell transplantation - single-centre experience
ŠKAPOVÁ, Denisa, Zdeněk RÁČIL, Dana DVOŘÁKOVÁ, Dagmar MINAŘÍKOVÁ, Jiří MAYER et. al.Základní údaje
Originální název
Significance of qualitative PCR detection metod for preemtive therapy of cytomegalovirus infection in patiens after allogeneic hematopoietic stem cell transplantation - single-centre experience
Autoři
ŠKAPOVÁ, Denisa, Zdeněk RÁČIL, Dana DVOŘÁKOVÁ, Dagmar MINAŘÍKOVÁ a Jiří MAYER
Vydání
Neoplasma, Bratislava, Veda, Slovak Academy Sciences, 2005, 0028-2685
Další údaje
Typ výsledku
Článek v odborném periodiku
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 0.731
Organizační jednotka
Lékařská fakulta
UT WoS
000228311600008
Klíčová slova anglicky
cytomegalovirus; polymerase chain reaction; allogeneic hematopoietic stem cell transplantation
Změněno: 3. 11. 2010 15:25, prof. MUDr. Zdeněk Ráčil, Ph.D.
Anotace
V originále
Both early cytomegalovirus (CMV) monitoring and prophylactic antiviral therapy can decrease clinical complications or can prevent them in patients after allogeneic hematopoietic stem cell transplantation (HSCT). Presented paper summarizes experiences with using regular monitoring of reactivation of CMV after allogencic HSCT by qualitative polymerase chain reaction (PCR) method to prevent the development of symptomatic CMV disease. Samples of peripheral blood leukocytes (PBL) in 71 patients were monitored. Because of retransplantations in two patients, 73 transplantations, each followed by the monitoring, were performed. Patients were monitored weekly after the transplantation for CMV DNAemia in PBL. An episode of CMV infection representing an indication for pre-emptive ganciclovir (GCV) or foscarnet (FOS) therapy was defined as two consecutive positive PCR results in 4-7 days. Median time of monitoring was 313 days. The CMV infection was found in 28/73 monitorings (38.4 %) and always was followed by pre-emptive therapy. One recurrence of CMV infection was observed in 4/28 (14.3 %) monitorings and two recurrences in 1/28 (3.6 %) monitorings. Presented approach resulted in complete prevention of overt CMV disease and this study enable to show that qualitative PCR method for determination of incipient CMV infection followed by pre-emptive therapy is suitable for preventing patients after allogeneic transplantation from CMV disease.